Skip to main content
Top

04-09-2017 | Ovarian cancer | Article

Tubal ligation and ovarian cancer risk in African American women

Journal: Cancer Causes & Control

Authors: Chrissy McNamara, Sarah E. Abbott, Elisa V. Bandera, Bo Qin, Lauren C. Peres, Fabian Camacho, Patricia G. Moorman, Anthony J. Alberg, Jill S. Barnholtz-Sloan, Melissa Bondy, Michele L. Cote, Ellen Funkhouser, Edward S. Peters, Ann G. Schwartz, Joellen M. Schildkraut, Paul Terry

Publisher: Springer International Publishing

Abstract

Purpose

Tubal ligation has been associated with reduced risk of epithelial ovarian cancer (EOC) in studies of primarily white women, but less is known about the association in African American (AA) women. We sought to evaluate the associations among 597 invasive ovarian cancer cases and 742 controls of AA descent recruited from the African American Cancer Epidemiology Study, a population-based case–control study in 11 geographical areas in the US.

Methods

Multivariable logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) adjusted for potentially confounding factors.

Results

An inverse association between tubal ligation and EOC was observed that was not statistically significant (OR 0.88, 95% CI 0.68–1.14). However, an inverse association with EOC risk was observed among women who had a tubal ligation at age 35 years or older (OR 0.64; 95% CI 0.41–0.98), but not among those who had a tubal ligation before age 35 (OR 0.98; 95% CI 0.74–1.29) (p for interaction = 0.08). The association also varied considerably by tumor subtype. A strong inverse association was observed for endometrioid tumors (OR 0.31, 95% CI 0.14–0.70), whereas associations with mucinous (OR 0.87, 95% CI 0.36–2.12) and serous (OR 0.94, 95% CI 0.71–1.24) tumors were weaker and not statistically significant. A statistically non-significant positive association for clear cell tumors (OR 1.84, 95% CI 0.58–5.82) was based on a low number of cases.

Conclusions

Our findings show that tubal ligation may confer a reduced risk for EOC among AA women that is comparable to the associations that have been previously observed in primarily white populations.
Literature
1.
Cancer Facts & Figures (2016) A. C. Society, Ed., ed. Atlanta
2.
Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM (2011) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data, (in eng). Gynecol Oncol 125:19–24CrossRefPubMed
3.
Gaitskell K et al (2016) Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study, (in eng). Br J Cancer 114:1033–1037CrossRefPubMedPubMedCentral
4.
Wu AH, Pearce CL, Tseng CC, Pike MC (2015) African Americans and Hispanics remain at lower risk of ovarian cancer than non-hispanic whites after considering nongenetic risk factors and oophorectomy rates, (in eng). Cancer Epidemiol Biomarkers Prev 24:1094–1100CrossRefPubMedPubMedCentral
5.
Madsen C, Baandrup L, Dehlendorff C, Kjaer SK (2014) Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study, (in eng). Acta Obstet Gynecol Scand 94:86–94CrossRefPubMed
6.
Rice MS, Hankinson SE, Tworoger SS (2014) Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the nurses’ health studies, (in eng). Fertil Steril 102:192–198CrossRefPubMedPubMedCentral
7.
Rice MS et al (2013) Tubal ligation, hysterectomy and epithelial ovarian cancer in the new england case–control study, (in eng). Int J Cancer 133:2415–2421CrossRefPubMedPubMedCentral
8.
Sieh W et al (2013) Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case–control studies, (in eng). Int J Epidemiol 42:579–589CrossRefPubMedPubMedCentral
9.
Wentzensen N et al (2016) Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium, (in eng). J Clin Oncol 34(24):2888–2898CrossRefPubMedPubMedCentral
10.
Rice MS, Murphy MA, Tworoger SS (2012) Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis, (in eng). J Ovarian Res 5:13CrossRefPubMedPubMedCentral
11.
Gates MA, Rosner BA, Hecht JL, Tworoger SS (2009) Risk factors for epithelial ovarian cancer by histologic subtype, (in eng). Am J Epidemiol 171:45–53CrossRefPubMedPubMedCentral
12.
Moorman PG, Palmieri RT, Akushevich L, Berchuck A, Schildkraut JM (2009) Ovarian cancer risk factors in African-American and white women, (in eng). Am J Epidemiol 170:598–606CrossRefPubMedPubMedCentral
13.
Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC (2008) Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors, (in eng). Eur J Cancer 44:2477–2484CrossRefPubMed
14.
Shu XO, Brinton LA, Gao YT, Yuan JM (1989) Population-based case–control study of ovarian cancer in Shanghai, (in eng). Cancer Res 49:3670–3674PubMed
15.
Alberg AJ et al (2016) Socioeconomic status in relation to the risk of ovarian cancer in African-American Women: a population-based case–control study, (in eng). Am J Epidemiol 184:274–283CrossRefPubMedPubMedCentral
16.
Ness RB, Grisso JA, Klapper J, Vergona R (2000) Racial differences in ovarian cancer risk, (in eng). J Natl Med Assoc 92:176–182PubMedPubMedCentral
17.
Kjaer SK, Mellemkjaer L, Brinton LA, Johansen C, Gridley G, Olsen JH (2004) Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65,000 sterilized women, (in eng). Int J Epidemiol 33:596–602CrossRefPubMed
18.
Tung KH et al (2003) Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case–control study, (in eng). Am J Epidemiol 158:629–638CrossRefPubMed
19.
Modugno F, Ness RB, Wheeler JE (2001) Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness, (in eng). Ann Epidemiol 11:568–574CrossRefPubMed
20.
Rosenblatt KA, Thomas DB (1996) Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives, (in eng). Cancer Epidemiol Biomark Prev 5:933–935
21.
McCluggage WG (2011) Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis, (in eng). Pathology 43:420–432CrossRefPubMed
22.
Dehlendorf C, Park SY, Emeremni CA, Comer D, Vincett K, Borrero S (2014) Racial/ethnic disparities in contraceptive use: variation by age and women’s reproductive experiences, (in eng). Am J Obstet Gynecol 210:526CrossRefPubMedPubMedCentral
23.
Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM (2016) Current cigarette smoking among adults—United States, 2005–2015, (in eng). MMWR Morb Mortal Wkly Rep 65(44):1205–1211CrossRefPubMed
24.
Brown AF et al (1999) Ethnic differences in hormone replacement prescribing patterns, (in eng). J Gen Intern Med 14(11):663–669CrossRefPubMedPubMedCentral
25.
Centers for Disease Control and Prevention (2006) Racial and socioeconomic disparities in breastfeeding–United States, 2004, (in eng). MMWR Morb Mortal Wkly Rep 55(12):335–339
26.
Kim S, Dolecek TA, Davis FG (2010) Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach, (in eng). Soc Sci Med 71:274–281CrossRefPubMedPubMedCentral
27.
Du XL, Sun CC, Milam MR, Bodurka DC, Fang S (2007) Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer, (in eng). Int J Gynecol Cancer 18:660–669CrossRefPubMed
28.
Barnholtz-Sloan JS et al (2002) Ethnic differences in survival among women with ovarian carcinoma, (in eng). Cancer 94:1886–1893CrossRefPubMed
29.
Bower JK, Schreiner PJ, Sternfeld B, Lewis CE (2009) Black-White differences in hysterectomy prevalence: the CARDIA study, (in eng). Am J Public Health 99(2):300–307CrossRefPubMedPubMedCentral
30.
Ogden CL, Carroll MD, Fryar CD, Flegal KM (2015) Prevalence of obesity among adults and youth: United States, 2011–2014, (in eng). NCHS Data Brief 219:1–8
31.
Bandera EV et al (2016) Obesity, weight gain, and ovarian cancer risk in African American women, (in eng). Int J Cancer 139(3):593–600CrossRefPubMedPubMedCentral
32.
Schildkraut JM et al (2014) A multi-center population-based case–control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES), (in eng). BMC Cancer 14:688CrossRefPubMedPubMedCentral
33.
Schildkraut JM et al (2016) Association between body powder use and ovarian cancer: the African American Cancer Epidemiology Study (AACES), (in Eng). Cancer Epidemiol Biomarkers Prev 25:1411–1417CrossRefPubMed
34.
Pearce CL et al (2015) Population distribution of lifetime risk of ovarian cancer in the United States, (in eng). Cancer Epidemiol Biomark Prev 24:671–676CrossRef
35.
McLaughlin JR et al (2007) Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case–control study, (in eng). Lancet Oncol 8:26–34CrossRefPubMed
36.
Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors, (in eng). Semin Surg Oncol 19:3–10CrossRefPubMed
37.
John EM, Whittemore AS, Harris R, Itnyre J (1993) Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case–control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group, (in eng). J Natl Cancer Inst 85:142–147CrossRefPubMed
38.
Hoyo C et al (2005) Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women, (in eng). Cancer Causes Control 16:955–963CrossRefPubMed
39.
Park HK, Ruterbusch JJ, Cote ML (2017) Recent trends in ovarian cancer incidence and relative survival in the US by race/ethnicity and histologic subtypes, (in eng). Cancer Epidemiol Biomark Prev. doi:10.​1158/​1055-9965.​EPI-17-0290
40.
Falconer H, Yin L, Gronberg H, Altman D (2015) Ovarian cancer risk after salpingectomy: a nationwide population-based study, (in eng). J Natl Cancer Inst 107:410CrossRef
41.
Gaitskell K, Green J, Pirie K, Reeves G, Beral V (2015) Tubal ligation and ovarian cancer risk in a large cohort: substantial variation by histological type, (in eng). Int J Cancer 138:1076–1084CrossRefPubMedPubMedCentral
42.
Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB (2010) Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer, (in eng). Ann Epidemiol 21:188–196CrossRefPubMedPubMedCentral
43.
Miracle-McMahill HL et al (1997) “Tubal ligation and fatal ovarian cancer in a large prospective cohort study,” (in eng). Am J Epidemiol 145:349–357CrossRefPubMed
44.
Hankinson SE et al (1993) Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study, (in eng). JAMA 270:2813–2818CrossRefPubMed
45.
Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group, (in eng). Am J Epidemiol 136:1184–1203CrossRefPubMed
46.
Irwin KL, Weiss NS, Lee NC, Peterson HB (1991) Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer, (in eng). Am J Epidemiol 134:362–369CrossRefPubMed
47.
Booth M, Beral V, Smith P (1989) Risk factors for ovarian cancer: a case–control study, (in eng). Br J Cancer 60:592–598CrossRefPubMedPubMedCentral
48.
Cibula D, Widschwendter M, Zikan M, Dusek L (2011) Underlying mechanisms of ovarian cancer risk reduction after tubal ligation, (in eng). Acta Obstet Gynecol Scand 90:559–563CrossRefPubMed
49.
Erickson BK, Conner MG, Landen CN Jr (2013) The role of the fallopian tube in the origin of ovarian cancer, (in eng). Am J Obstet Gynecol 209(5):409–414CrossRefPubMedPubMedCentral
50.
Cheng W, Liu J, Yoshida H, Rosen D, Naora H (2005) Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract, (in eng). Nat Med 11:531–537CrossRefPubMed
51.
Vang R, Shih M (2012) Fallopian tube precursors of ovarian low- and high-grade serous neoplasms, (in eng). Histopathology 62:44–58CrossRef
52.
Massuger L, Roelofsen T, Ham M, Bulten J (2009) The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis, (in eng). Med Hypotheses 74:859–861CrossRefPubMed
53.
Bowtell DD et al (2015) Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer, (in eng). Nat Rev Cancer 15:668–679CrossRefPubMedPubMedCentral
54.
Cibula D, Widschwendter M, Majek O, Dusek L (2010) Tubal ligation and the risk of ovarian cancer: review and meta-analysis, (in eng). Hum Reprod Update 17:55–67CrossRefPubMed
55.
Chilvers CE, Pike MC, Taylor CN, Hermon C, Crossley B, Smith SJ (1994) General practitioner notes as a source of information for case-control studies in young women. UK National Case–Control Study Group, (in eng). J Epidemiol Commun Health 48:92–97CrossRef